A one-stop service is being set up in Finland to streamline the use of data on well-being in research. The service, which will be more flexible than the one that is now in use, will boost biobank research, explains Johanna Arola, Acting CEO at FinBioBank in this short blog and video.
In the future, new treatments will be developed faster than before, using samples given to biobanks and the health data that is linked to them meaning all patients can be research patients in the future. Combining and studying data will enable the development of individualised treatments for serious illnesses.
In biobank research, the human focus is a key factor. Patients and sample donors give their consent to the use of samples and at the same time maintain their right to know what their samples are being used for.
More flexible availability of data on well-being will expedite and streamline biobank research. Alongside others, FinBioBank, a new co-operative of Finnish biobanks, is currently setting up a shared service of biobank data to achieve this.
This is the third part of Sitra’s series of videos and blogs for Precision Medicine Forum. The first, by Sitra’s Project Director, Digital Health Hub, Jaana Sinipuro can be viewed here, and the second by Hannu Hämäläinen, Ministerial Adviser, Ministry of Social Affairs and Health can be viewed here.
Jaana Sinipuro from SITRA will be speaking at the Nordic Precision Medicine Forum in March 2018. You can register for the event here.